Form D · Pharmaceuticals
Enfuego Therapeutics, Inc.
Pittsboro, NC · CIK 0001866961
Offering snapshot reported Oct 28, 2025 · SEC filing
- Reported sold
- $1M Offering amount: $2.5M
- Investors reported
- 12 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 15, 2021 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$500,000 → $1,000,000
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 28, 2025 | Amendment | $1,000,000 | $500,000vs Jun 28, 2021 | 12 | SEC filing |
| Jun 28, 2021 | Initial | $500,000 | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Security to be acquired
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-404453
Source: Form D, filed Oct 28, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Michael Dombeck | Director, Executive |
| Sue Mahony | Director |
| Joe Mc Mahon | Director |
| Chad V. Pecot | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:Pittsboro, NC, 27312
Phone: 615-305-3955